KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $745.0 million.

  • Medtronic's Depreciation & Amortization (CF) rose 1037.04% to $745.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $3.0 billion, marking a year-over-year increase of 1428.03%. This contributed to the annual value of $2.9 billion for FY2025, which is 808.46% up from last year.
  • Medtronic's Depreciation & Amortization (CF) amounted to $745.0 million in Q4 2025, which was up 1037.04% from $748.0 million recorded in Q3 2025.
  • Over the past 5 years, Medtronic's Depreciation & Amortization (CF) peaked at $840.0 million during Q2 2025, and registered a low of $649.0 million during Q1 2024.
  • Its 5-year average for Depreciation & Amortization (CF) is $688.4 million, with a median of $675.5 million in 2021.
  • As far as peak fluctuations go, Medtronic's Depreciation & Amortization (CF) plummeted by 441.83% in 2024, and later soared by 2844.04% in 2025.
  • Medtronic's Depreciation & Amortization (CF) (Quarter) stood at $676.0 million in 2021, then decreased by 0.74% to $671.0 million in 2022, then increased by 0.15% to $672.0 million in 2023, then rose by 0.45% to $675.0 million in 2024, then rose by 10.37% to $745.0 million in 2025.
  • Its Depreciation & Amortization (CF) was $745.0 million in Q4 2025, compared to $748.0 million in Q3 2025 and $840.0 million in Q2 2025.